pI: 5.1004 |
Length (AA): 307 |
MW (Da): 32872 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 305 | 1u0r (D) | 2 | 305 | 99.99 | 0 | 1 | 2.15573 | -0.72 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127041)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G21070 | NAD(H) kinase 1 |
Arabidopsis thaliana | AT1G21640 | NAD kinase 2 |
Babesia bovis | BBOV_IV002800 | ATP-NAD-dependent kinase, putative |
Candida albicans | CaO19.7393 | NAD kinase associated with ferric reductase |
Cryptosporidium hominis | Chro.80231 | inorganic polyphosphate/ATP-NAD kinase |
Cryptosporidium parvum | cgd8_1970 | NAD kinase involved in polyphosphate metabolism |
Dictyostelium discoideum | DDB_G0272224 | NAD+ kinase family protein |
Dictyostelium discoideum | DDB_G0292442 | NAD+ kinase family protein |
Drosophila melanogaster | Dmel_CG33156 | CG33156 gene product from transcript CG33156-RF |
Drosophila melanogaster | Dmel_CG6145 | CG6145 gene product from transcript CG6145-RE |
Escherichia coli | b2615 | NAD kinase |
Echinococcus granulosus | EgrG_000193300 | NAD kinase |
Echinococcus multilocularis | EmuJ_000193300 | NAD kinase |
Giardia lamblia | GL50803_17316 | Inorganic polyphosphate/ATP-NAD kinase, putative |
Homo sapiens | ENSG00000008130 | NAD kinase |
Mycobacterium leprae | ML1359 | Inorganic polyphosphate/ATP-NAD kinase PpnK (Poly(P)/ATP NAD kinase) |
Mus musculus | ENSMUSG00000029063 | NAD kinase |
Mycobacterium tuberculosis | Rv1695 | Inorganic polyphosphate/ATP-NAD kinase PpnK (poly(P)/ATP NAD kinase) |
Mycobacterium ulcerans | MUL_1684 | inorganic polyphosphate/ATP-NAD kinase |
Neospora caninum | NCLIV_019250 | ATP-NAD/AcoX kinase, related |
Oryza sativa | 4349979 | Os11g0191400 |
Oryza sativa | 4325416 | Os01g0957000 |
Oryza sativa | 9266739 | Os05g0388400 |
Saccharomyces cerevisiae | YEL041W | Yef1p |
Saccharomyces cerevisiae | YJR049C | Utr1p |
Schistosoma japonicum | Sjp_0065130 | ko:K00858 NAD+ kinase [EC2.7.1.23], putative |
Schistosoma mansoni | Smp_094870 | poly(p)/ATP NAD kinase |
Schmidtea mediterranea | mk4.064899.00 | |
Schmidtea mediterranea | mk4.024641.00 | |
Schmidtea mediterranea | mk4.001685.02 | |
Treponema pallidum | TP0441 | hypothetical protein |
Theileria parva | TP03_0366 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_485920 | poly(p)/ATP NAD kinase, putative |
Trichomonas vaginalis | TVAG_056970 | poly(p)/ATP NAD kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b2615 | Escherichia coli | essential | goodall |
YJR049C | Saccharomyces cerevisiae | inviable | yeastgenome |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Compound | Source | Reference |
---|---|---|
References | ||
References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Staphylococcus aureus (strain COL) | NAD kinase | Compounds | References |
Listeria monocytogenes serotype 4b (strain F2365) | NAD kinase 1 | Compounds | References |
Homo sapiens | NAD kinase | Compounds | References |